Amdocs Stock Price, News & Analysis (NASDAQ:DOX)

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs declared a quarterly dividend on Wednesday, August 7th. Stockholders of record on Monday, September 30th will be given a dividend of $0.285 per share on Friday, October 25th. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date of this dividend is Friday, September 27th. View Amdocs' Dividend History.

Amdocs declared that its board has authorized a stock repurchase program on Thursday, November 9th 2017, which authorizes the company to repurchase $800,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.

Amdocs Limited (NASDAQ:DOX) released its quarterly earnings results on Wednesday, August, 7th. The technology company reported $1.19 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.11 by $0.08. The technology company earned $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Amdocs had a net margin of 9.90% and a return on equity of 15.70%. The firm's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.03 earnings per share. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Amdocs.

Amdocs will be holding an earnings conference call on Tuesday, November 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Amdocs issued an update on its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $4.28-4.34 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.28. The company issued revenue guidance of $4.070233088-4.109981458 billion, compared to the consensus revenue estimate of $4.09 billion.

1 Wall Street analysts have issued 12-month target prices for Amdocs' shares. Their forecasts range from $75.00 to $75.00. On average, they expect Amdocs' stock price to reach $75.00 in the next year. This suggests a possible upside of 15.7% from the stock's current price. View Analyst Price Targets for Amdocs.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Amdocs.

News articles about DOX stock have trended somewhat positive recently, InfoTrie reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Amdocs earned a news sentiment score of 0.9 on InfoTrie's scale. They also gave headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Amdocs.

Amdocs saw a decrease in short interest in the month of September. As of September 30th, there was short interest totalling 2,390,000 shares, a decrease of 9.1% from the August 30th total of 2,630,000 shares. Based on an average trading volume of 589,600 shares, the days-to-cover ratio is currently 4.1 days. Approximately 1.8% of the company's stock are short sold. View Amdocs' Current Options Chain.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), Gartner (IT), Leidos (LDOS), EPAM Systems (EPAM), Booz Allen Hamilton (BAH), Caci International (CACI), Teradata (TDC), Mantech International (MANT), Virtusa (VRTU), Forrester Research (FORR), The Hackett Group (HCKT), Unisys (UIS) and Servicesource International (SREV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include QUALCOMM (QCOM), Home Depot (HD), Activision Blizzard (ATVI), Alphabet (GOOG), Micron Technology (MU), AbbVie (ABBV), Boeing (BA), Caterpillar (CAT), Chevron (CVX) and Enterprise Products Partners (EPD).

Amdocs' stock is owned by many different of institutional and retail investors. Top institutional investors include Robeco Institutional Asset Management B.V. (0.99%), Boston Trust Walden Corp (0.19%), Rhumbline Advisers (0.17%), Envestnet Asset Management Inc. (0.15%), Denali Advisors LLC (0.07%) and Zurcher Kantonalbank Zurich Cantonalbank (0.05%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C., CenturyLink Investment Management Co, Denali Advisors LLC, Cerebellum GP LLC, Bowling Portfolio Management LLC, Rhumbline Advisers and Regentatlantic Capital LLC.

DOX stock was purchased by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank , Robeco Institutional Asset Management B.V., Envestnet Asset Management Inc., State of Alaska Department of Revenue, Henry James International Management Inc., Boston Trust Walden Corp, Brinker Capital Inc. and Arden Trust Co.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $64.82.

Amdocs has a market capitalization of $9.05 billion and generates $3.97 billion in revenue each year. The technology company earns $354.39 million in net income (profit) each year or $3.74 on an earnings per share basis. Amdocs employs 24,381 workers across the globe.View Additional Information About Amdocs.

The official website for Amdocs is http://www.amdocs.com/.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]